SyMRI 15 is a state-of-the-art imaging solution set to redefine medical imaging with a range of innovative applications integrated into its post-processing suite.

Alongside the previously launched SyMRI 3D (version 14), the updated solution now includes images proven to match conventional ones for diagnostic purposes, offering added value within the same imaging sequence.

Backed by a large multi-center study across prominent institutes in the United States, SyMRI 15 has demonstrated its ability to replace traditional 3D images with its SyMRI T1 and T2 counterparts, boosting efficiency and throughput.

It enhances diagnostic accuracy with quantitative values and tissue segmentation capabilities already established.

The new release introduces tools for efficient patient monitoring, providing contrast-weighted images and quantitative information.

This empowers clinicians with deeper insights into patient health, facilitating improved patient care through comprehensive understanding of disease progression and treatment effects over time.

"They are excited to announce the CE marking for Version 15 of our SyMRI 3D solution," said, CEO of SyntheticMR AB.

"This next generation of SyMRI 3D delivers unmatched resolution and accuracy in brain imaging, transforming medical diagnostics."

SyntheticMR has an exclusive distribution agreement with Philips Healthcare for SyMRI 15, ensuring its inclusion in Philips' global price book and expanding its accessibility to customers worldwide.

The CE marking for SyMRI 3D represents a significant milestone for SyntheticMR, reinforcing its commitment to advancing medical imaging technology on a global scale.

Source: prnewswire.com

Report Abuse